RXQ Compounding, LLC

RXQ Compounding, LLC RXQ Compounding, LLC is an FDA Registered 503(B) Outsourcing Facility, located in Albany, Ohio. All products are manufactured in ISO 5 laminar flow hoods.

RXQ Compounding emerged in front of new regulations from the FDA governing compounding facilities and the state board of pharmacy to assure that the safest products are delivered to our customers and patients. Our team works closely with FDA regulators and legislators in following the new guidelines. For more information visit www.RXQCompounding.com or contact us directly at (866) 280-0031. Our te

am designed and implemented a stringent procedural manual that is now copyrighted. Others who follow into this new realm will be hard pressed to find a more complete adaptation of the new regulations. We have partnered with the Ohio University Innovation Center to develop a viable enterprise here in Southern Ohio. RXQ Compounding, LLC is poised to be a leader in the new paradigm of manufacturing facilities across the country. Guarantee safety, availability, and compliance by making
RXQ Compounding, LLC your FDA 503B Outsourcing Facility.

One of our great customers and good friend in New Orleans. Congrats Dr. Mary.
04/21/2023

One of our great customers and good friend in New Orleans. Congrats Dr. Mary.

Address

2364 Blizzard Lane
Albany, OH
45710

Website

Alerts

Be the first to know and let us send you an email when RXQ Compounding, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to RXQ Compounding, LLC:

Share

Our Story

RXQ Compounding, LLC is an FDA Registered 503B Outsourcing Facility, located in Albany, OH. We have partnered with the Ohio Innovation Fund to develop a viable enterprise here in Southern Ohio. RXQ Compounding, LLC is poised to be a leader in the new paradigm of manufacturing facilities across the country. Our team designed and implemented a stringent procedural manual that is now copyrighted. Other 503B Outsourcing Facilities that follow into this new realm will be hard pressed to find a more complete adaptation of the new regulations.

RXQ Compounding, LLC emerged in front of new regulations from the FDA governing compounding facilities and the state board of pharmacy to assure that the safest products are delivered to our customers and patients. Edward Zatta, RPh, Founder and CEO, and our other highly-trained team of pharmacists, laboratory technicians, and quality control managers work closely with FDA regulators and legislators in following all new guidelines.

At RXQ Compounding, LLC, we manufacture sterile and non-sterile medications including products that are on the FDA Short List. We provide these medications to physician offices and hospitals across the United States in various sized vials and syringes. We are currently licensed to ship to 40 states and Washington, DC and are rapidly acquiring licenses for other states.

RXQ must comply with current good manufacturing practice (CGMP) guidelines and US Pharmacopeia Guidelines (USP) and we are subject to risk-based inspections by the Federal Drug Administration at any time. Our products do not require a patient prescription and can be used for office use. As an FDA 503B Outsourcing Facility, we are required by the FDA to follow strict testing standards for sterility, potency, and endotoxins. Our products are compounded in ISO 5 clean rooms that are continuously monitored for particulate matter and environmental conditions.